摘要 |
The invention provides Listeria that, in addition to comprising polynucleotides that encode heterologous polypeptides such as tumor or infectious agent antigens, have been modified to express holin proteins that facilitate the delivery of the heterologous polypeptides, or polynucleotides encoding the same, outside of the bacteria. In some particular embodiments, the Listeria generate viral-derived, self-replicating RNAs that direct expression of the heterologous polypeptides in the cytosol of infected cells. Methods of using the Listeria, and compositions thereof, to induce immune response and/or in the prevention or treatment of disease are also provided. Methods of producing the bacteria are also provided. |
申请人 |
ANZA THERAPEUTICS, INC.;LAUER, PETER, M.;DUBENSKY, THOMAS, W.;LUCKETT, WILLIAM, S.;HANSON, WILLIAM, G. |
发明人 |
LAUER, PETER, M.;DUBENSKY, THOMAS, W.;LUCKETT, WILLIAM, S.;HANSON, WILLIAM, G. |